Matches in Wikidata for { <http://www.wikidata.org/entity/Q62660116> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q62660116 description "im April 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q62660116 description "wetenschappelijk artikel" @default.
- Q62660116 description "наукова стаття, опублікована у квітні 2016" @default.
- Q62660116 name "Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab" @default.
- Q62660116 name "Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab" @default.
- Q62660116 type Item @default.
- Q62660116 label "Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab" @default.
- Q62660116 label "Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab" @default.
- Q62660116 prefLabel "Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab" @default.
- Q62660116 prefLabel "Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab" @default.
- Q62660116 P1433 Q62660116-B17EE586-D505-4D8D-A1DB-BA8F9122D063 @default.
- Q62660116 P1476 Q62660116-619E9BAE-40E9-4AC6-A2E6-611867B4BB82 @default.
- Q62660116 P2093 Q62660116-420FAE09-AF95-465F-84CF-0B416ACBA861 @default.
- Q62660116 P2093 Q62660116-44541883-21F7-496C-AA83-AF23BE53BD12 @default.
- Q62660116 P2093 Q62660116-51881B1F-EFB5-49A4-9B3C-899A9895F1CD @default.
- Q62660116 P2093 Q62660116-5EB76E5E-CA60-4417-8E7D-EA1706E993BB @default.
- Q62660116 P2093 Q62660116-83860952-E6D5-4411-B23C-54EC6D0AB12E @default.
- Q62660116 P2093 Q62660116-FF8773D2-9C8B-42FD-8DC7-E573828B2849 @default.
- Q62660116 P304 Q62660116-8A2CC145-9DA3-48AA-87BF-59AC61E5F522 @default.
- Q62660116 P31 Q62660116-41AADDF8-1011-4109-8D30-042FD6389FD0 @default.
- Q62660116 P356 Q62660116-0C510C29-E20C-42A4-B697-EFA252E96579 @default.
- Q62660116 P407 Q62660116-74E0FBD8-8686-4E20-B085-05E6970DB08A @default.
- Q62660116 P433 Q62660116-A6D6963A-EBA4-469C-A7A8-6D498287C8A2 @default.
- Q62660116 P478 Q62660116-74C32211-EEB3-4936-AEDB-DA60306BD476 @default.
- Q62660116 P50 Q62660116-744B6A97-EE26-45A7-9C6E-88A7FA752C2C @default.
- Q62660116 P50 Q62660116-763E53A8-CE02-4B9A-9744-4134B6569EDF @default.
- Q62660116 P577 Q62660116-25EFBB87-8BB9-402E-BDCA-98970055E5E2 @default.
- Q62660116 P921 Q62660116-1BB6A120-2EE2-4D47-B63B-5B93363196E5 @default.
- Q62660116 P921 Q62660116-5815AF73-B3C6-4924-BBDD-FEBE21CF1DA8 @default.
- Q62660116 P356 S0016-5085(16)32751-2 @default.
- Q62660116 P1433 Q4039279 @default.
- Q62660116 P1476 "Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab" @default.
- Q62660116 P2093 "Julien Branche" @default.
- Q62660116 P2093 "Maria Nachury" @default.
- Q62660116 P2093 "Medina Boualit" @default.
- Q62660116 P2093 "Nicolas Duveau" @default.
- Q62660116 P2093 "Romain Gerard" @default.
- Q62660116 P2093 "Vincent Maunoury" @default.
- Q62660116 P304 "S813-S814" @default.
- Q62660116 P31 Q13442814 @default.
- Q62660116 P356 "10.1016/S0016-5085(16)32751-2" @default.
- Q62660116 P407 Q1860 @default.
- Q62660116 P433 "4" @default.
- Q62660116 P478 "150" @default.
- Q62660116 P50 Q56952654 @default.
- Q62660116 P50 Q56979864 @default.
- Q62660116 P577 "2016-04-01T00:00:00Z" @default.
- Q62660116 P921 Q1472 @default.
- Q62660116 P921 Q348260 @default.